참고문헌
- Boonjaraspinyo S, Boonmars T, Kaewkes S, et al (2012a). Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma. Pathol Oncol Res, 18, 227-37. https://doi.org/10.1007/s12253-011-9432-5
- Boonjaraspinyo S, Boonmars T, Wu Z, et al (2012b). Plateletderived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma. Tumour Biol, 33, 1785-802. https://doi.org/10.1007/s13277-012-0438-8
- Boonmars T, Wu Z, Boonjaruspinyo S, et al (2011). Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine. Pathol Oncol Res, 17, 219-27. https://doi.org/10.1007/s12253-010-9300-8
- Drecoll E, Nitsche U, Bauer K, et al (2014). Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma. Int J Colorectal Dis, 29, 663-71. https://doi.org/10.1007/s00384-014-1857-3
- Friman S (2011). Cholangiocarcinoma-current treatment options. Scand J Surg, 100, 30-4.
- Hong DS, Banerji U, Tavana B, et al (2013). Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions. Cancer Treat Rev, 39, 375-87. https://doi.org/10.1016/j.ctrv.2012.10.001
- IARC (2011). Opisthorchis viverrini and Clonorchis sinensis IARC. Monogr Eval Carcinog Risks Hum, 100, 347-76.
- Jego G, Hazoume A, Seigneuric R, et al (2013). Targeting heat shock proteins in cancer. Cancer Lett, 332, 275-85. https://doi.org/10.1016/j.canlet.2010.10.014
- Juasook A, Aukkanimart R, Boonmars T, et al (2013). Tumorrelated gene changes in immunosuppressive Syrian hamster cholangiocarcinoma. Pathol Oncol Res, 19, 785-94. https://doi.org/10.1007/s12253-013-9645-x
- Khalil AA, Kabapy NF, Deraz SF, et al (2011). Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets? Biochim Biophys Acta, 1816, 89-104.
- Khan SA, Davidson BR, Goldin RD, et al (2012). Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut, 61, 1657-69. https://doi.org/10.1136/gutjnl-2011-301748
- Kim JY, Yenari MA (2013). The immune modulating properties of the heat shock proteins after brain injury. Anat Cell Biol, 46, 1-7. https://doi.org/10.5115/acb.2013.46.1.1
- Li W, Sahu D, Tsen F (2012). Secreted heat shock protein-90 (Hsp90) in wound healing and cancer. Biochim Biophys Acta, 1823, 730-41. https://doi.org/10.1016/j.bbamcr.2011.09.009
- Messaoudi S, Peyrat JF, Brion JD, et al (2011). Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010. Expert Opin Ther Pat, 21, 1501-42. https://doi.org/10.1517/13543776.2011.594041
- Patel HJ, Modi S, Chiosis G, et al (2011). Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment. Expert Opin Drug Discov, 6, 559-87. https://doi.org/10.1517/17460441.2011.563296
- Ruys AT, van Haelst S, Busch OR, et al (2012). Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg, 36, 2179-86. https://doi.org/10.1007/s00268-012-1638-5
- Schiffman SC, Reuter NP, McMasters KM, et al (2011). Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol, [Epub ahead of print].
- Sithithaworn P, Yongvanit P, Duenngai K, et al (2014). Roles of liver fluke infection as risk factor for cholangiocarcinoma. J Hepatobiliary Pancreat Sci, 21, 301-8. https://doi.org/10.1002/jhbp.62
- Tomcik M, Zerr P, Pitkowski J, et al (2014). Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-beta signalling to prevent fibrosis. Ann Rheum Dis, 73, 1215-22.